|
| Description |
This activity was presented at the Cleveland Clinic Richard J. Fasenmyer Center of Clinical Immunology Biologic Therapies for Autoimmune and Inflammatory Disease States Summit. The reviewed advances in biologic therapies for autoimmune diseases. |
| Target Audience |
This activity will be directed to rheumatologists, gastroenterologists, dermatologists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals interested in or using biologic therapeutics in autoimmune and inflammatory disorders. |
| Objectives |
At the conclusion of this activity, the participant will be able to:
- Recognize the most common infections associated with the use of TNF-α inhibitors.
- List preventative screening measures to reduce infectious complications associated with the use of TNF-α inhibitors.
- Identify risks for opportunistic infections across available agents and classes.
- Identify granulomatous infections and treatment with available agents.
- Identify data on hepatic toxicity form biologic anti-rheumatic therapies.
|
| Accreditation |
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit. |
| Activity Director |
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic and Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology |
| Faculty |
Marc D. Cohen, MD
Chairman, Division of Rheumatology
Professor of Medicine
Mayo Clinic College of Medicine
Jacksonville, Florida
|
Jack Cush, MD
Chief, Rheumatology and Clinical Immunology
Presbyterian Hospital of Dallas
Clinical Professor of Medicine
The University of Texas Southwestern
Medical School
Dallas, Texas |
Jerrold J. Ellner, MD
University Professor UMDNJ
Professor of Medicine
New Jersey Medical Center
Newark, New Jersey |
Thomas File, MD
Professor, Northeastern Ohio Universities
College of Medicine
Chief of the Infectious Disease Service
Akron City Hospital
Summa Health Systems
Akron, Ohio |
Richard Rudick, MD
Chairman, Division of Clinical Research
Director, Mellen Center for Multiple Sclerosis
Treatment and Research
Cleveland Clinic
Cleveland, Ohio |
|
| Faculty Disclosure |
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Leonard Calabrese, DO |
|
Consulting, Teaching and Speaking
|
Genentech |
|
Teaching and Speaking |
Abbott; Amgen; Wyeth |
| |
| Marc Cohen, MD |
|
Teaching and Speaking |
Abbott; BMS; Centocor
|
| |
Consulting, Teaching and Speaking:
|
Amgen; Genentech |
| |
Consulting |
Wyeth |
| |
| Jack Cush, MD |
|
Consulting, Teaching and Speaking
|
Abbott Pharmaceuticals |
|
Consulting |
Wyeth |
| |
Consulting and Independent Contractor |
Centocor; UCB |
| |
| Thomas File, MD |
|
Research, Consulting and Speaker’s Bureau |
Bayer; Binax Incorporated; GlaxoSmithKline; Merck; Ortho-McNeil; Oscient; Pfizer;
Sanofi-Aventis; Schering-Plough; Wyeth |
| |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
|
Jerrold J. Ellner, MD
Richard Rudick, MD |
|
The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for support of this activity from:
 |
 |
 |
| Genentech and Biogen Idec. |
 |
 |
Gold Level
This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education and UNITECH Communications®.
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity. |
